Caredx, INC Form 4 insider transactions

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported a transaction in 2,872 shares of common stock on August 1, 2026.

John Walter Hanna Jr, President and CEO and a Director of CareDx, Inc., sold 118,000 shares of common stock on July 16, 2026.

Hannah Valantine, a Director of CareDx, Inc., sold 28,779 shares of common stock on July 16, 2026.

Michael Goldberg, a Director at CareDx, Inc., received a grant of 1,746 shares of common stock as part of his non-employee director compensation.

CareDx Chief Commercial Officer Jessica Meng reported a transaction involving company common stock, including shares withheld for tax obligations and shares acquired through an employee stock purchase plan.

CareDx CFO & COO Keith Kennedy reports a transaction involving common stock, including shares withheld for tax obligations and shares acquired through an employee stock purchase plan.

CareDx, Inc. President and CEO John Walter Hanna Jr. reported a series of stock transactions, including acquisitions and sales, executed under a pre-established Rule 10b5-1 trading plan.

Director Hannah Valantine acquired 9,795 restricted stock units and sold 12,103 shares of CareDx, Inc. common stock.

Director Christine Cournoyer was granted 9,795 restricted stock units in CareDx, Inc. as part of standard equity compensation.

Director Richard Bryan Riggsbee was granted 9,795 restricted stock units in CareDx, Inc. as part of standard equity compensation.

Director Fred E. Cohen was granted 9,795 restricted stock units as part of his compensation package at CareDx, Inc.

Director Suresh Gunasekaran was granted 9,795 restricted stock units in CareDx, Inc. as part of standard equity compensation.

Director George Bickerstaff acquired 9,795 restricted stock units in CareDx, Inc. as part of a standard equity compensation grant.

Director Michael Goldberg acquired 9,795 restricted stock units in CareDx, Inc. as part of an equity compensation grant.

CareDx, Inc. President and CEO, John Walter Hanna Jr., sold 21,998 shares of common stock for approximately $24.02 per share under a pre-arranged trading plan.

CareDx Secretary and General Counsel Jeffrey Adam Novack reported a transaction involving the withholding of shares to cover tax obligations.

CareDx, Inc. President and CEO John Walter Hanna Jr. reported the sale of 4,835 shares of common stock for approximately $24.00 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

CareDx Director Arthur A. Torres reported transactions involving the sale of company common stock.

CareDx, Inc. reports that Secretary and General Counsel Jeffrey Adam Novack sold 2,688 shares of common stock for $20.6775 per share, executed under a pre-arranged 10b5-1 trading plan.

CareDx, Inc. officer Jeffrey Adam Novack reported a transaction involving the withholding of shares to cover tax obligations.

CareDx President and CEO John Walter Hanna Jr. sold 10,282 shares of common stock at $21.12 per share.

CareDx President and CEO John Walter Hanna Jr. disposed of 62,049 shares of common stock to satisfy tax withholding requirements.

CareDx, Inc. officer Jeffrey Adam Novack acquired 1,892 shares of common stock through a tax withholding transaction on April 6, 2026.

CareDx, Inc. President and CEO John Walter Hanna Jr. reported a transaction involving the withholding of shares to cover tax obligations.

CareDx, Inc. CFO & COO Keith Kennedy acquired 11,725 shares of common stock for $17.87 per share, a transaction related to tax withholding obligations upon vesting of restricted stock units.

CareDx Chief Commercial Officer Jessica Meng reported a transaction involving the withholding of shares to cover tax obligations.

CareDx, Inc. officer Jeffrey Adam Novack reported a disposition of 3,987 shares of common stock on April 1, 2026, to cover tax withholding obligations.

Michael Goldberg, a Director at CareDx, Inc., received a quarterly stock grant of 1,981 shares as compensation.

CareDx Director Michael Goldberg reported exercising stock options for 26,500 shares of common stock, effective March 31, 2026, under a pre-arranged trading plan.

CareDx Chief Operating Officer Keith Kennedy increased his direct beneficial ownership of common stock through RSU awards and PRSU vesting, partially offset by shares withheld for tax obligations.